UK MHRA Medical Device Registration

UK MHRA Medical Device Registration: Entering the UK medical device market requires careful navigation through the Medicines and Healthcare products Regulatory Agency (MHRA) requirements. Masuu Global Solutions streamlines the registration journey by reviewing your technical documentation, preparing compliant submissions through the Device Online Registration System (DORS), and ensuring that your products meet all UK‑specific regulatory expectations.

As an experienced UK Responsible Person (UKRP), Masuu acts as your official representative to the MHRA managing registrations, post‑market surveillance, vigilance communication, and CE‑to‑UKCA transitions. Our team keeps you updated with regulatory developments while ensuring your device remains compliant throughout its lifecycle.

Ensuring Seamless Compliance with UK MDR & MHRA Requirements

Foreign manufacturers placing devices on the UK market must comply with the UK Medical Devices Regulations 2002 (as amended). All medical devices and IVDs must be registered with MHRA before commercialization. Non‑UK manufacturers are legally required to appoint a UK Responsible Person (UKRP) to act on their behalf.

With evolving UK requirements including new guidance from the MHRA’s regulatory reform consultation—manufacturers often face challenges such as:
  • Unclear CE‑to‑UKCA transition requirements
  • Data gaps and incomplete technical files
  • Device reclassification and documentation updates
  • Learning to navigate the DORS registration platform

Masuu Global Solutions removes these barriers. We manage the entire UK registration process, verify documentation, handle all MHRA interactions, and ensure you remain compliant throughout product launch and post‑market stages.

Step-by-Step UK Medical Device Registration Process

Masuu manages the entire UK registration workflow, including:
  1. Device classification and regulatory pathway assessment
  2. UKRP appointment and legal representation setup
  3. Technical documentation & labeling review
  4. DORS registration & submission management
  5. UKCA or CE certificate verification
  6. Compliance check for PMS, vigilance, and QMS requirements
  7. Ongoing regulatory monitoring & support
Typical processing time: 2–6 weeks depending on device type and dossier completeness.

Masuu UK Medical Device Registration – Key Offerings

Device Registration (DORS)

We handle full MHRA device registration, ensuring accurate listings, compliant submissions, and timely approvals for all device classes.

UK Responsible Person (UKRP) Services

As your UKRP, Masuu:
  • Represents you legally to the MHRA
  • Maintains your documentation for inspections
  • Ensures continuous compliance
  • Oversees vigilance and PMS activities

Technical File / Dossier Compilation

We prepare UK‑aligned documentation for UKCA marking and CE‑transition readiness, ensuring audit‑ready technical files.

QMS Support

We assist in implementing and maintaining ISO 13485‑compliant quality systems tailored to UK regulatory expectations.

Regulatory Writing

Masuu prepares CERs, PMS plans, PSURs, risk management files, and other supporting documents with clarity and regulatory precision.

Labeling & Packaging Compliance

We ensure your labeling, packaging, and IFUs meet UKCA requirements, including language and symbol compliance.

Post‑Market Surveillance (PMS)

Masuu manages PMS plans, adverse event submissions, vigilance notifications, and MHRA communications to maintain continued market access.

Masuu UK Responsible Person (UKRP) – Service Offering

  1. Device Registration with MHRA
  2. We manage your complete registration through DORS, ensuring correct listings and smooth approval.
  1. Documentation & Conformity Assurance
  2. We verify and maintain:
    • Declarations of Conformity
    • Technical documentation
    • CE/UKCA product certifications
    • All files required for MHRA audit requests
  1. Responding to MHRA Queries
  2. We handle all MHRA queries, follow‑ups, and clarifications on your behalf to ensure prompt resolution.
  1. Vigilance & Safety Communication
  2. As your primary liaison, we coordinate all safety‑related reports, including FSCA, incident updates, and adverse event communication.
  1. Inspection & Audit Readiness
  2. Masuu ensures all records, labeling proof, PMS documentation, and technical files remain audit‑ready and fully compliant.

Why Partner with Masuu Global Solutions?

  • End‑to‑end regulatory expertise across pre‑market, post‑market, and lifecycle compliance
  • A proven history of supporting 1500+ device registrations across multiple categories
  • Local presence in the UK with dedicated regulatory specialists
  • Strategic guidance for seamless CE → UKCA transition
  • Direct MHRA liaison for faster communication and approvals
  • Trusted by hundreds of global manufacturers as their long‑term UK regulatory partner

Frequently Asked Questions

Medical devices and IVDs must be registered with the UK Medicines and Healthcare products Regulatory Agency (MHRA) before commercialization in the UK. The process includes determining the applicable regulatory pathway, preparing technical documentation, appointing a UK Responsible Person when required, and completing registration through the Device Online Registration System (DORS).

Yes. Manufacturers located outside the UK must appoint a UK Responsible Person (UKRP) to act on their behalf for UK regulatory matters. The UKRP represents the manufacturer to the MHRA, supports registration, maintains required documentation, and assists with post-market surveillance, vigilance communications, and regulatory compliance.

MHRA registration requires appropriate regulatory and product documentation, including technical documentation, labeling, declarations of conformity, and applicable CE or UKCA certification. The exact documentation depends on the device and regulatory pathway. Manufacturers should also ensure that PMS, vigilance, risk management, and quality-system documentation are available for regulatory review.

DORS is the MHRA’s online system used for medical device registration. Manufacturers or their UK Responsible Person submit the required device and manufacturer information through the platform. Before submission, the device classification, technical documentation, conformity evidence, and UK representation details should be verified to reduce registration issues.

CE-marked medical devices may be accepted in the UK under applicable transitional arrangements, subject to the relevant UK requirements and timelines. Manufacturers should verify whether their existing CE certification qualifies for the applicable transition period and whether additional UK registration or UK Responsible Person requirements apply before placing the device on the UK market.

UKCA is the UK conformity marking framework, while CE marking relates to applicable European regulatory requirements. Manufacturers entering the UK market need to determine whether their devices can continue using CE marking under transitional provisions or need to transition to UKCA. The applicable route depends on the device and current UK regulatory requirements.

The typical processing time for UK medical device registration is approximately 2–6 weeks, depending on the device type and completeness of the submitted dossier. Delays can occur when technical documentation, conformity certificates, manufacturer information, or other required registration details are incomplete or require clarification.

Registration is not the end of the UK compliance process. Manufacturers must maintain applicable quality, post-market surveillance, vigilance, and documentation requirements throughout the device lifecycle. This can include adverse-event reporting, safety communications, PMS activities, technical-file maintenance, and responding to MHRA requests or inspections.

UK medical device technical documentation should demonstrate that the device meets applicable regulatory and safety requirements. Depending on the device and conformity route, documentation can include technical files, declarations of conformity, certificates, risk management records, clinical evaluation reports, PMS documentation, and labeling or instructions for use.

Manufacturers must maintain appropriate post-market surveillance and vigilance processes after placing medical devices on the UK market. These activities can include monitoring device safety, managing incidents and adverse events, submitting required safety communications, handling field safety corrective actions, and maintaining relevant PMS documentation for MHRA compliance.

Book a Demo